WTX-124
WTX-124x2101
Phase 1 small_molecule active
Quick answer
WTX-124 for Metastatic Solid Tumor is a Phase 1 program (small_molecule) at Werewolf Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Werewolf Therapeutics
- Indication
- Metastatic Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active